Innovative Medicines Canada has an effective and engaged Board of Directors that enables member companies to achieve common objectives.
Ronnie W. Miller, Hoffmann-La Roche Limited
Al Reba, Bristol-Myers Squibb Canada
Jared Rhines, Akcea Therapeutics Canada Inc.
Jorge Bartolome, Janssen Inc.
Jane Chung, AstraZeneca Canada Inc.
Ed Dybka, Ipsen Biopharmaceuticals Canada, Inc.
John Haslam, Horizon Therapeutics Canada Inc.
Brian Heath, Amgen Canada Inc.
Alok Kanti, Bayer Inc.
Christian Macher, Novartis Pharmaceuticals Canada Inc.
Lisa Mullett, Sunovion Pharmaceuticals Canada Inc.
Cole Pinnow, Pfizer Canada ULC
Marissa Poole, Sanofi Canada
Frank Stramaglia, Astellas Pharma Canada, Inc.
Anna van Acker, Merck Canada Inc.